‘People told me my plans for a skincare firm were crazy’

The BBC’s weekly The Boss series profiles different business leaders from around the world. This week we speak to Tata Harper, owner of the popular US skincare company of the same name.

Tata Harper’s mission to create a natural skincare range began when her stepfather was diagnosed with cancer in 2005.

His doctors advised him to adopt a healthier lifestyle. They wanted him to reduce the amount of toxins and synthetic chemicals he was exposing his body to, be it through the food he was eating, or what he was putting on his skin, from shampoo to soap.

Ms Harper says it made her realise that she, and the rest of the family, also needed to make the change.

“While I was looking for new products for him, I was also looking for new products for me, because I was trying to make my life more healthy,” says the 44-year-old

Read More

This VC Firm Is Offering MBAs $100K To Take A Gap Year

Coronavirus is pushing business schools online. Recession is pushing employees and interns out of work. Is this the perfect time to take a “gap year” — defer starting that MBA program or suspend that job search and work on personal growth and passion projects?

Eric Tarczynski thinks so. The founder of Contrary Capital, a university-focused venture fund, Tarczynski is banking on the entrepreneurial chops of the talent in, and close to, higher education, and on that talent’s desire to launch now — no more waiting, now. Literally banking on it — Contrary is offering up to $100,000 to as many as five teams with ideas for new companies.

What are they looking for? Anything. Good ideas that can become good, and great, companies. Just bring the brainpower and the dedication to see your idea through. In addition to the funding, Contrary will connect the selected teams with entrepreneurial experts,

Read More

China firm uses workers to ‘pre-test’ vaccine in global race

BEIJING (AP) — In the global race to make a coronavirus vaccine, a state-owned Chinese company is boasting that its employees, including top executives, received experimental shots even before the government approved testing in people.

“Giving a helping hand in forging the sword of victory,” reads an online post from SinoPharm with pictures of workers it says helped “pre-test” its vaccine.

Whether it’s viewed as heroic sacrifice or a violation of international ethical norms, the claim underscores the enormous stakes as China competes with U.S. and British companies to be the first with a vaccine to help end the pandemic — a feat that would be both a scientific and political triumph.

“Getting a COVID-19 vaccine is the new Holy Grail,” said Lawrence Gostin, a global public health law expert at Georgetown University. “The political competition to be the first is no less consequential than the race for the moon

Read More